NIH-funded research NIH-funded research

Using integrated approaches to develop therapies for healthy aging

Official title: Integrative Omics to enhance therapeutics development for healthy aging

Funded at Translational Genomics Research Inst · NIH-10693877 · Data updated 2026-11-12

This study is looking for ways to help people age healthier by finding signs in our bodies that are linked to living longer, and it's for anyone interested in how we can prevent diseases as we get older.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionTranslational Genomics Research Inst
NIH-funded
Lab location1 site (Phoenix, United States)
Project startSeptember 15, 2019
Project endAugust 31, 2025
Funding year2023
Award (this year)$878,314
NIH project number5UH3AG064706-05
Project IDNIH-10693877 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults interested in interventions that promote healthy aging and longevity.

Less likely to help

Patients with acute age-related diseases or those who are not yet experiencing age-related health issues may not benefit from this research.

What this research studies

This research investigates how to enhance therapeutic development aimed at promoting healthy aging by identifying biological markers associated with longevity. It employs a combination of human longitudinal studies and cross-species analyses to discover metabolites and proteins that contribute to slow aging and the prevention of age-related diseases. By integrating data from various sources, the research aims to uncover common pathways that could lead to effective interventions for extending human lifespan and improving health in older adults.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that significantly improve health and longevity in aging populations.

How similar studies have gone: Previous research has shown promise in using integrated approaches to understand aging and develop longevity-enhancing therapies, indicating a potential for success in this area.

Where this research is happening

  • Translational Genomics Research Inst
    Phoenix, United States
    Active

Researchers

  • Principal investigator: Schork, Nicholas Joseph — Translational Genomics Research Inst
  • Study coordinator: Schork, Nicholas Joseph

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.